MarketInOut Stock Screener Log In | Sign Up
 

Sunshine Biopharma Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
Sunshine Biopharma Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.22 mln
Float4.06 mln
Earnings Date11/10/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.51
Likely reliable

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-16%
Loss-making

ROE

-23.91
Deeply negative

Business Description

Sunshine Biopharma is a Fort Lauderdale-based company working to develop new treatments for serious diseases, including cancer and viral infections, while also selling a broad range of existing generic medications across the United States and Canada. Its drug pipeline includes treatments targeting pancreatic cancer, liver cancer, and coronavirus infections. The company also sells over-the-counter health products such as amino acid supplements, calcium and vitamin D tablets, and other nutritional items.

Key Fundamentals

EPS-9.45
ROE-23.91
RPS49.67
ROIC-33.29
ROA-18.80
EBITDA, mln-5.21
EV / EBITDA2.33
EV / EBIT2.18
Revenue, mln35.35

Quote Details

Last 0.15
Change -0.017 (-10.18%)
Open 0.17
Volume 2,158,424
Turnover 323,764
Average Volume 15,218,918

Financial Ratios

Pre-Tax Profit Margin-16
Leverage Ratio1.22
Current Ratio5.46
Price / Book0.07
Price / Tangible Book0.07
Debt / Equity0.03
Price / Sales0.01

Financial Strength

Altman Z-Score-1.54
Piotroski F-Score 4 / 9
Beneish M-Score-2.51
Short Ratio0.85
Short % of Float3.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -32.37% 3 / 100   
1 Month -81.25% 1 / 100   
2 Months -91.33% 1 / 100   
6 Months -98.5% 1 / 100   
1 Year -99.18% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog